238 related articles for article (PubMed ID: 1309969)
1. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
2. [Variety of neutrophil chemotactic factors in the respiratory tracts in patients with respiratory diseases].
Hayashi H; Ozaki T; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):580-6. PubMed ID: 2214401
[TBL] [Abstract][Full Text] [Related]
3. [C5 contents and neutrophil chemotactic activities in bronchiolar and alveolar regions].
Hayashi H; Ozaki T; Nakamura Y; Kamei T; Kawaji K; Tani K; Noda Y; Ogushi F; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jun; 29(6):677-84. PubMed ID: 1895584
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases.
Oishi K; Sonoda F; Kobayashi S; Iwagaki A; Nagatake T; Matsushima K; Matsumoto K
Infect Immun; 1994 Oct; 62(10):4145-52. PubMed ID: 7927669
[TBL] [Abstract][Full Text] [Related]
6. [Neutrophil chemotactic factor in lung injury produced by immune complexes].
Tanoue M
Arerugi; 1989 Nov; 38(11):1209-16. PubMed ID: 2697200
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals.
Hayes AA; Rose AH; Musk AW; Robinson BW
Chest; 1988 Sep; 94(3):521-5. PubMed ID: 3044701
[TBL] [Abstract][Full Text] [Related]
9. Tannin-mediated secretion of a neutrophil chemotactic factor from alveolar macrophages. Potential contribution to the acute pulmonary inflammatory reaction associated with byssinosis.
Rohrbach MS; Kreofsky T; Rolstad RA; Russell JA
Am Rev Respir Dis; 1989 Jan; 139(1):39-45. PubMed ID: 2492174
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis or idiopathic pulmonary fibrosis.
Ogushi F; Tani K; Maniwa K; Ichikawa W; Tada H; Kawano T; Sone S
J Med Invest; 1997 Aug; 44(1-2):53-8. PubMed ID: 9395718
[TBL] [Abstract][Full Text] [Related]
11. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
12. Role of alveolar macrophages in the neutrophil-dependent defense system against Pseudomonas aeruginosa infection in the lower respiratory tract. Amplifying effect of muramyl dipeptide analog.
Ozaki T; Maeda M; Hayashi H; Nakamura Y; Moriguchi H; Kamei T; Yasuoka S; Ogura T
Am Rev Respir Dis; 1989 Dec; 140(6):1595-601. PubMed ID: 2513762
[TBL] [Abstract][Full Text] [Related]
13. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis.
Strausz J; Müller-Quernheim J; Steppling H; Ferlinz R
Am Rev Respir Dis; 1990 Jan; 141(1):124-8. PubMed ID: 2297170
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
Hunninghake GW; Gadek JE; Lawley TJ; Crystal RG
J Clin Invest; 1981 Jul; 68(1):259-69. PubMed ID: 7251862
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis.
Carré PC; Mortenson RL; King TE; Noble PW; Sable CL; Riches DW
J Clin Invest; 1991 Dec; 88(6):1802-10. PubMed ID: 1752942
[TBL] [Abstract][Full Text] [Related]
17. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Car BD; Meloni F; Luisetti M; Semenzato G; Gialdroni-Grassi G; Walz A
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):655-9. PubMed ID: 8118632
[TBL] [Abstract][Full Text] [Related]
18. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
19. Asbestos-induced release of a human alveolar macrophage-derived neutrophil chemotactic factor.
Hayes AA; Venaille TJ; Rose AH; Musk AW; Robinson BW
Exp Lung Res; 1990; 16(2):121-30. PubMed ID: 2184026
[TBL] [Abstract][Full Text] [Related]
20. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
